Endosc Int Open 2015; 03(03): E195-E201
DOI: 10.1055/s-0034-1391668
Original article
© Georg Thieme Verlag KG Stuttgart · New York

Peroral endoscopic myotomy (POEM) vs laparoscopic Heller myotomy (LHM) for the treatment of Type III achalasia in 75 patients: a multicenter comparative study

Vivek Kumbhari
1  Johns Hopkins Medical Institutions, Gastroenterology and Hepatology, Baltimore, Maryland, United States
,
Alan H Tieu
1  Johns Hopkins Medical Institutions, Gastroenterology and Hepatology, Baltimore, Maryland, United States
,
Manabu Onimaru
2  Showa University Northern Yokohama Hospital, Digestive Disease Center, Yokohama, Japan
,
Mohammad H. El Zein
1  Johns Hopkins Medical Institutions, Gastroenterology and Hepatology, Baltimore, Maryland, United States
,
Ezra N. Teitelbaum
3  Northwestern University Feinberg School of Medicine, Department of Surgery, Chicago, Illinois, United States
,
Michael B. Ujiki
4  NorthShore University Health Systems, NorthShore Center for Simulation and Innovation, Evanston, Illinois, United States
,
Matthew E. Gitelis
4  NorthShore University Health Systems, NorthShore Center for Simulation and Innovation, Evanston, Illinois, United States
,
Rani J. Modayil
5  Winthrop University Hospital, Gastroenterology and Hepatology, Mineola, New York, United States
,
Eric S. Hungness
3  Northwestern University Feinberg School of Medicine, Department of Surgery, Chicago, Illinois, United States
,
Stavros N. Stavropoulos
5  Winthrop University Hospital, Gastroenterology and Hepatology, Mineola, New York, United States
,
Hiro Shiwaku
6  Fukuoka University Faculty of Medicine, Gastroenterology and Hepatology, Fukuoka, Japan
,
Rastislav Kunda
7  Aarhus University Hospital, Department of Surgery, Aarhus, Denmark
,
Philip Chiu
8  Institute of Digestive Disease, Gastroenterology and Hepatology, Shatin, Hong Kong
,
Payal Saxena
1  Johns Hopkins Medical Institutions, Gastroenterology and Hepatology, Baltimore, Maryland, United States
,
Ahmed A. Messallam
1  Johns Hopkins Medical Institutions, Gastroenterology and Hepatology, Baltimore, Maryland, United States
,
Haruhiro Inoue
2  Showa University Northern Yokohama Hospital, Digestive Disease Center, Yokohama, Japan
,
Mouen A. Khashab
1  Johns Hopkins Medical Institutions, Gastroenterology and Hepatology, Baltimore, Maryland, United States
› Author Affiliations
Further Information

Publication History

submitted 22 November 2014

accepted after revision 08 December 2014

Publication Date:
13 April 2015 (online)

Background and study aims: Type III achalasia is characterized by rapidly propagating pressurization attributable to spastic contractions. Although laparoscopic Heller myotomy (LHM) is the current gold standard management for type III achalasia, peroral endoscopic myotomy (POEM) is conceivably superior because it allows for a longer myotomy. Our aims were to compare the efficacy and safety of POEM with LHM for type III achalasia patients.

Patients and methods: A retrospective study of 49 patients who underwent POEM for type III achalasia across eight centers were compared to 26 patients who underwent LHM at a single institution. Procedural data were abstracted and pre- and post-procedural symptoms were recorded. Clinical response was defined by improvement of symptoms and decrease in Eckardt stage to ≤ 1. Secondary outcomes included length of myotomy, procedure duration, length of hospital stay, and rate of adverse events.

Results: Clinical response was significantly more frequent in the POEM cohort (98.0 % vs 80.8 %; P = 0.01). POEM patients had significantly shorter mean procedure time than LHM patients (102 min vs 264 min; P < 0.01) despite longer length of myotomy (16 cm vs 8 cm; P < 0.01). There was no significant difference between POEM and LHM in the length of hospital stay (3.3 days vs 3.2 days; P = 0.68), respectively. Rate of adverse events was significantly less in the POEM group (6 % vs 27 %; P < 0.01).

Conclusions: POEM allows for a longer myotomy than LHM, which may result in improved clinical outcomes. POEM appears to be an effective and safe alternative to LHM in patients with type III achalasia.